The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin

Steven L. Flamm(Northwestern University), Sammy Saab(Mount Sinai Medical Center), Patrizia Burra(University of Padua), Fred Poordad(The University of Texas at San Antonio Health Science Center), Milagros Samaniego(Henry Ford Health System), Robert S. Brown(Cornell University), Marcelo Kugelmas(University of Colorado Health), Kimberly Brown(Henry Ford Health System), Hani M. Wadei(Johns Hopkins University)
Liver Transplantation
April 14, 2021
10.1002/lt.26072
Cited by 53

Related Papers

KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
|Hepatology|2013|1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
|Hepatology|2008|865
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837